Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review

Guidelines recommend that treatment with a long-acting β2 agonist (LABA), a long-acting muscarinic antagonist (LAMA), and inhaled corticosteroids (ICS), i.e. triple therapy, is reserved for a select group of symp...
Source: Respiratory Research - Category: Respiratory Medicine Authors: Tags: Review Source Type: research